Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by smartbroker12on Oct 17, 2018 2:11pm
244 Views
Post# 28820884

Its final now: NYSE confirmed the listing on NYSE

Its final now: NYSE confirmed the listing on NYSE

Aurora Cannabis gets green light for NYSE listing

It’s a good day for Aurora Cannabis Inc. The Edmonton-based cannabis producer has received approval to list its shares on the New York Stock Exchange on the same day it’s playing a part in the debut of legal recreational cannabis in Canada.

The NYSE certified its approval for listing and registration on the U.S. exchange, according to a filing with the U.S. Securities and Exchange Commission, marking a significant milestone for Aurora as it becomes another Canadian-based cannabis producer to tap into the U.S. capital market.

Aurora Cannabis previously announced its intention to seek an NYSE listing on Oct. 9, saying at the time it expected its shares to begin trading before the end of this month. Now Aurora is poised to share the U.S. stage with some of its peers including Canopy Growth Corp., which also trades on the NYSE, and Cronos Group, which trades on the NASDAQ.

Aurora Chief Corporate Officer Cam Battley told BNN Bloomberg Wednesday afternoon his company hasn’t received confirmation of what day shares will begin trading on the NYSE.

Aurora shares were trading down 0.79 per cent to $13.87 on the Toronto Stock Exchange at 12:38 p.m. ET Wednesday, paring some of their earlier losses as investors opted to move broadly out of the cannabis sector on the same day that recreational marijuana was legalized in Canada.  

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new – and controversial – Canadian recreational marijuana industry. Read more from the special series here and subscribe to our Cannabis Canada newsletter to have the latest marijuana news delivered directly to your inbox every day.Aurora Cannabis Gets Green Light for NYSE listing :)

Bullboard Posts